The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2020

Filed:

Apr. 22, 2016
Applicant:

The Rockefeller University, New York, NY (US);

Inventors:

Howard Hang, New York, NY (US);

Kavita Rangan, New York, NY (US);

Daniel Mucida, New York, NY (US);

Virginia Pedicord, New York, NY (US);

Assignee:

THE ROCKEFELLER UNIVERSITY, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/31 (2006.01); C07K 14/315 (2006.01); A23K 10/18 (2016.01); A23L 33/135 (2016.01); A61P 31/04 (2006.01); A23C 9/12 (2006.01); A23C 9/123 (2006.01); A61K 35/744 (2015.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/315 (2013.01); A23C 9/1203 (2013.01); A23C 9/1234 (2013.01); A23K 10/18 (2016.05); A23L 33/135 (2016.08); A61K 35/744 (2013.01); A61P 31/04 (2018.01); A23V 2002/00 (2013.01); A23Y 2220/67 (2013.01); A61K 2035/11 (2013.01);
Abstract

Provided are compositions and methods based in part on the discovery thatheterologous secreted antigen A (SagA)-produced peptidoglycan fragments are protective against enteric bacterial infections. Modified bacteria that are engineered to express heterologous SagA are provided, and are included a nutraceutical, pharmaceutical, and probiotic formulations, and as components of food products, including dairy products. The modified bacteria include modifiedbacteria that express heterologous SagA. The disclosure includes a method that involves introducing into an individual modified bacteria of that express and secrete heterologous SagA. The disclosure provides isolated peptidoglycan fragment preparations made by a exposing a composition that contains peptidoglycan to an isolated or recombinant SagA, or to modified bacteria expressing a heterologous SagA, allowing SagA to generate the peptidoglycan fragments, and separating the peptidoglycan fragments from the composition to obtain the isolated peptidoglycan fragments or a preparation that contains them.


Find Patent Forward Citations

Loading…